Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other financing activities: 2020-2025

Historic Other financing activities for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $2.3 million.

  • Benitec Biopharma's Other financing activities fell 97.54% to $72,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year decrease of 43.86%. This contributed to the annual value of $2.3 million for FY2025, which is 60.64% down from last year.
  • As of FY2025, Benitec Biopharma's Other financing activities stood at $2.3 million, which was down 60.64% from $5.9 million recorded in FY2024.
  • Benitec Biopharma's Other financing activities' 5-year high stood at $5.9 million during FY2024, with a 5-year trough of $1.9 million in FY2023.
  • Moreover, its 3-year median value for Other financing activities was $2.3 million (2025), whereas its average is $3.4 million.
  • As far as peak fluctuations go, Benitec Biopharma's Other financing activities soared by 572.50% in 2021, and later slumped by 60.64% in 2025.
  • Benitec Biopharma's Other financing activities (Yearly) stood at $3.2 million in 2021, then reached $1.9 million in 2023, then skyrocketed by 215.25% to $5.9 million in 2024, then plummeted by 60.64% to $2.3 million in 2025.